Lead sponsor
Chendu DIAO Pharmaceutical Group CO., LTD.
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
1
Trials led
0
Active
250
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Completed
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment